Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review

The probability of right heart thrombus co‐existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The prevention and management of intracardiac thrombotic events include early use of anticoagulation therapy.

Detalles Bibliográficos
Autores principales: Abdelmahmuod, Elabbass A., Hamad, Abdelrahman, Almaghraby, Ahmed, Mohamed, Samah, Alkuwari, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133078/
https://www.ncbi.nlm.nih.gov/pubmed/34026171
http://dx.doi.org/10.1002/ccr3.4137
Descripción
Sumario:The probability of right heart thrombus co‐existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The prevention and management of intracardiac thrombotic events include early use of anticoagulation therapy.

Ejemplares similares